This paper is in the following e-collection/theme issue:

Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (788) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1570) Neurology and Neurosciences (149)

Published on in Vol 20, No 10 (2018): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11168, first published .
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study

The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study

The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study

Authors of this article:

Kristina F Simacek1 Author Orcid Image ;   John J Ko2 Author Orcid Image ;   Debbie Moreton3 Author Orcid Image ;   Stefan Varga4 Author Orcid Image ;   Kristen Johnson2 Author Orcid Image ;   Bozena J Katic1 Author Orcid Image
Article Authors Cited by (31) Tweetations (10) Metrics

Kristina F Simacek   1 , MA, PhD ;   John J Ko   2 , MS, PharmD ;   Debbie Moreton   3 , BS ;   Stefan Varga   4 , PharmD ;   Kristen Johnson   2 , MPH, PhD ;   Bozena J Katic   1 , MPH, PhD

1 Research and Development, PatientsLikeMe, Cambridge, MA, United States

2 Health Economic and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States

3 PatientsLikeMe, Cambridge, MA, United States

4 Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, PA, United States

Corresponding Author: